Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Boeing
BA
|
$960M |
| 2 |
Netflix
NFLX
|
$766M |
| 3 |
UnitedHealth
UNH
|
$629M |
| 4 |
Trade Desk
TTD
|
$502M |
| 5 |
Broadcom
AVGO
|
$420M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$2.27B |
| 2 |
Uber
UBER
|
$772M |
| 3 |
Tesla
TSLA
|
$749M |
| 4 |
DexCom
DXCM
|
$486M |
| 5 |
argenx
ARGX
|
$473M |
Sector Composition
| 1 | Technology | 38.73% |
| 2 | Consumer Discretionary | 19.7% |
| 3 | Healthcare | 12.45% |
| 4 | Communication Services | 10.23% |
| 5 | Financials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAG
426
DELISTED
MAG Silver
MAG
| $5.13M | ﹤0.01% |
492,536
-1,116
| -0.2% | -$11.6K |
|
427
Service Corp International
SCI
$10.9B
| $4.61M | ﹤0.01% |
67,334
-11,478
| -15% | -$786K |
|
428
Canadian Pacific Kansas City
CP
$70.3B
| $4.58M | ﹤0.01% |
57,878
+12,036
| +26% | +$952K |
|
429
James Hardie Industries plc
JHX
$11.7B
| $4.53M | ﹤0.01% |
+117,206
| New | +$4.53M |
|
430
Lifezone Metals
LZM
$365M
| $4.35M | ﹤0.01% |
+481,650
| New | +$4.35M |
|
431
Stantec
STN
$12.3B
| $4.06M | ﹤0.01% |
+50,524
| New | +$4.06M |
|
432
Enphase Energy
ENPH
$5.18B
| $4.03M | ﹤0.01% |
30,480
-5,737
| -16% | -$758K |
|
433
CSX Corp
CSX
$60.6B
| $3.98M | ﹤0.01% |
114,675
+13,159
| +13% | +$456K |
|
434
Exelixis
EXEL
$10.2B
| $3.94M | ﹤0.01% |
164,200
+815
| +0.5% | +$19.6K |
|
435
Insmed
INSM
$30.7B
| $3.74M | ﹤0.01% |
+120,831
| New | +$3.74M |
|
436
Synopsys
SNPS
$111B
| $3.69M | ﹤0.01% |
7,172
+517
| +8% | +$266K |
|
437
iShares MSCI ACWI ex US ETF
ACWX
$6.66B
| $3.64M | ﹤0.01% |
71,367
-18,982
| -21% | -$969K |
|
438
McCormick & Company Non-Voting
MKC
$19B
| $3.45M | ﹤0.01% |
50,399
-8,573
| -15% | -$587K |
|
439
TXO Partners LP
TXO
$743M
| $3.38M | ﹤0.01% |
185,985
-3,377
| -2% | -$61.4K |
|
|
LBPH
440
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.9M | ﹤0.01% |
+480,828
| New | +$2.9M |
|
441
Apogee Therapeutics
APGE
$2.26B
| $2.9M | ﹤0.01% |
+103,744
| New | +$2.9M |
|
|
FUSN
442
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.89M | ﹤0.01% |
+301,020
| New | +$2.89M |
|
443
Coca-Cola
KO
$292B
| $2.7M | ﹤0.01% |
45,816
-610
| -1% | -$35.9K |
|
444
Dyne Therapeutics
DYN
$2.02B
| $2.7M | ﹤0.01% |
+202,871
| New | +$2.7M |
|
|
ALPN
445
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.69M | ﹤0.01% |
+141,095
| New | +$2.69M |
|
446
Scholar Rock
SRRK
$3.02B
| $2.58M | ﹤0.01% |
+137,049
| New | +$2.58M |
|
447
Lockheed Martin
LMT
$108B
| $2.56M | ﹤0.01% |
5,639
-8,939
| -61% | -$4.05M |
|
448
Disc Medicine
IRON
$2.11B
| $2.49M | ﹤0.01% |
+43,031
| New | +$2.49M |
|
|
TE
449
T1 Energy Inc.
TE
$309M
| $2.42M | ﹤0.01% |
1,293,137
-53,206
| -4% | -$99.5K |
|
450
Rambus
RMBS
$8.05B
| $2.34M | ﹤0.01% |
34,331
+5,129
| +18% | +$350K |
|